Member Info for Safy

Tils inhaler works with other drugs too inc Roche and Sanofi as explained by Gabrielle.

So basically it improves the odds of some success on that front for us. Tils have 3 bites at the cherry. Even if our drug isn’t better than Roche or Sanofi, our inhaler can still be used.

Obviously we wants our drugs and inhaler to work better, but success for the other two is also a positive for us.

Sorry are Sanofi for phase III but they’ve got another late trial ongoing.

From the TILS RNS

Certain patients infected with coronavirus COVID-19 may develop an uncontrolled immune response ("cytokine storm") resulting in severe damage to lung tissue which could lead to respiratory failure (see Note 1, below). Early clinical studies conducted by doctors in China suggest that anti-IL6R mAbs may be used in clinical practice for treatment of COVID-19. Consequently, China's National Health Commission has recommended the use of Roche's blockbuster drug, Actemra® for treatment of patients infected with COVID-19, with serious lung damage and elevated IL-6 levels. Actemra was first approved by the FDA in 2010 for rheumatoid arthritis. Besides Actemra®, Sanofi and Regeneron are currently exploring Kevzara®, an FDA-approved anti-IL-6 receptor therapy for rheumatoid arthritis, for treatment of severe COVID-19.

Sanofi looks like they’ve had to go one step back to evaluate dosage, Roche has moved one step forward with positive feedback.

You may hear something by the month end or early next month.

It’s bloody annoying because after having done this research, these results were never on the cards at the end of last month, but rainbow chasers on this bb were posting ‘just waiting for results as they are due now!!’ Ffs

https://eyewire.news/articles/sanofi-regeneron-and-roche-report-mixed-results-for-potential-covid-19-treatments/

Roche are now in phase III trials which started recruiting last month.

It seems in principle the administration of the medicine is similar to SNG001.

Thanks tamer.

I think news on that will be what breaks the 120p resistance.

Does anyone have any idea of the timescales for patent approvals in the current climate?

Not much has been reported since it was filed.

Are you on Advfn?

If that’s the CEO with this atrocious writing style, I’m Matt Han**** and I’m confirming we are discussing using Avacta tests for the NHS and front line staff. LOL

Are people really believing this hahaaha

MrNation

How many times will you post the same messages over and over again. Everyone knows what you know. They’ve read it over a hundred times. LOL

If they announce some follow up Covid news it’ll get that bounce. But it seems that isn’t on the top of their agenda atm. And it wouldn’t surprise me if nothing came on that front.

The 90 resistance will be hard to break with low volumes. This will simmer along slowly, few percent here and there. I just hope it doesn’t drop back.

Does anybody know what happened between 14:00 and COB today? All pharmas dropped further in that time than at other points during the day. The patterns are very much identical.

In the present climate CE gets you 20-30 percent.

Look at TILS today, their cancer test is better than a gold standard test which cost over $1bn and it ended up 6% up.

AVCT sent their chems to the USA to make tests and they got 20%.

I think the days of 100% on each RNS are gone.

ODX, SNG, AVCT, GDR - ALL took a battering today and mostly all this week, and that’s when they are working on the most in demand product in the world atm.

We closed a few % up with no Covid plays in our recent RNS and whilst I don’t check TILS everyday we’ve closed up maybe all week. If the market was buoyant it would have been much better. But id rather be a plus on the day than be any of the above. That’s not saying those companies are bad. I’m saying put it into context. Long gone are the days when a covid RNS got you 100% straight of the bat. AVCT most recent RNS got 20% I think.

I never expected 100% today, it was never on the cards. What does bode well is more news regarding beating the market leader for tests. Is ours cheaper? Stuff like that...

I also believe there has to be a power play for the conference. You don’t play all your cards in advance. Some positive news must come out of it and it’s 2 weeks away. Till then we shouldn’t tank unless the whole market is tanking. That’s not TILS fault.

Gla

If 80-90 is a new baseline I’m comfortable with that. I came from 60% down and if you look back at my posts I have been TILS biggest critic.

My mindset was covid rainbows and nothing came. And this is the important bit, not much came through in the RNS sphere but still it slowly recovered my lost 60%!!!

It has to be a decent company to be able to do that. And now when we have actual news people are saying it’s tanking and a ****e company. **** right off!!!

Sam, thats total utter nonsense and you know it, its just recovered from 50p and we have positive news coming out. From which angle are you seeing this share going down to 50p. It might float around 80-90p for a bit. Most of the sellers are out.

I have a feeling we will continue to see more RNS on trials etc and hopefully see some steady gains. I dont think the company will let everything out of the bag before the conference otherwise the conference would be repeated everything from the posters which are already in the public domain.

More details will no doubt follow. This is a hold for me.

successful drug trial, which might be whats saving us from red today.

Sam,

I have never laughed at losing money but ive got the giggles right now. Its like ****ing de ja vu all over again for me. So close yet so far.

Some people might be offended with my post but trust me, if you've been through the **** like me and Sam on here you will know exactly what i mean.

on HL i could easily buy £10k, no issues at all

20-25% up if we are lucky. Dont expect huge things.